This morning, Bank of America lowered its price target on shares of Forest Laboratories (FRX) to $40 as demand for Dalresp and Savella has come in lighter than expected. Despite the lower price target though, Bank of America maintained its buy rating. Shares of FRX were higher despite the report, picking up 1.2% today.